Finance

Beta
Lists
4019:TADAWUL
Specialized Medical Company SCJSC
SAR 16.85
-0.12%
(-0.020) 1D
Jun 9, 3:17:51 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4019...
Open
SAR 16.89
High
SAR 16.94
Low
SAR 16.78
Mkt. cap
4.21B
Avg. vol.
425.13K
Volume
373.02K
Dividend
1.90%
Quarterly dividend
SAR 0.08
Ex-dividend date
May 18, 2026
P/E ratio
15.65
52-wk high
SAR 25.00
52-wk low
SAR 16.70
EPS
SAR 1.08
Shares outstanding
250.00M
No. of employees
3K
Open
SAR 16.89
High
SAR 16.94
Low
SAR 16.78
Mkt. cap
4.21B
Avg. vol.
425.13K
Volume
373.02K
Dividend
1.90%
Quarterly dividend
SAR 0.08
Ex-dividend date
May 18, 2026
P/E ratio
15.65
52-wk high
SAR 25.00
52-wk low
SAR 16.70
EPS
SAR 1.08
Shares outstanding
250.00M
No. of employees
3K
News stories
From sources across the web
About Specialized Medical Company SCJSC
CEO-
Employees3.35K
Founded1994
Headquarters-
SectorHealth care provider
Websitesmc.com.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
379.96M
382.69M
406.91M
380.67M
Cost of goods sold
278.05M
280.94M
323.31M
289.71M
Cost of revenue
278.05M
280.94M
323.31M
289.71M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.33M
27.85M
11.77M
49.88M
Operating expense
53.33M
27.85M
11.77M
49.88M
Total operating expenses
331.39M
308.79M
335.08M
339.59M
Operating income
48.58M
73.90M
71.83M
41.08M
Other non operating income
2.56M
6.98M
7.21M
2.98M
EBT including unusual items
38.12M
68.49M
134.75M
33.70M
EBT excluding unusual items
38.12M
68.49M
74.12M
33.70M
Income tax expense
1.76M
2.25M
766.56K
1.15M
Effective tax rate
4.61%
3.28%
0.57%
3.42%
Other operating expenses
-
-
-
-
Net income
36.36M
66.25M
133.98M
32.55M
Net profit margin
9.57%
17.31%
32.93%
8.55%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-13.02M
-12.39M
-4.92M
-10.36M
Net interest expenses
-13.02M
-12.39M
-4.92M
-10.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
64.07M
90.07M
87.47M
57.71M
Gain or loss from assets sale
-
170.94K
-60.66M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer